High Cholesterol

Clinical Trial Finder

Many patients with high cholesterol are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada

Condition:   Dyslipidemia
Intervention:   Other: survey
Sponsors:   Canadian Heart Research Centre;   Amgen
Enrolling by invitation - verified August 2015

Effect of Simvastatin Withdrawal on Ocular Endothelial Function

Condition:   Healthy
Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Laser Doppler Velocimetry (LDV);   Drug: Simvastatin
Sponsor:   Medical University of Vienna
Not yet recruiting - verified August 2015

Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia

Condition:   Familial Hypercholesterolemia
Interventions:   Other: Pre-lipid apheresis;   Other: Post-lipid apheresis
Sponsor:   Laval University
Not yet recruiting - verified August 2015

Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

Condition:   Hypercholesterolemia
Interventions:   Drug: alirocumab SAR236553/REGN727;   Drug: placebo
Sponsor:   Sanofi
Recruiting - verified August 2015

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Condition:   Hyperlipidemia
Interventions:   Drug: Evacetrapib;   Drug: Atorvastatin;   Drug: Ezetimibe;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified August 2015

CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)

Condition:   Dyslipidaemia
Sponsor:   AstraZeneca
Recruiting - verified August 2015

Open Label Study of Long Term Safety Evaluation of Alirocumab

Condition:   Hypercholesterolemia
Intervention:   Drug: Alirocumab SAR236553 (REGN727)
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Active, not recruiting - verified August 2015

Effects of Colesevelam

Condition:   Sitosterolemia
Interventions:   Drug: Colesevelam;   Other: Placebo
Sponsor:   University of Manitoba
Not yet recruiting - verified August 2015

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

Condition:   Hypercholesterolemia
Interventions:   Drug: Anacetrapib;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified August 2015

A Study of MK6213 Co-Administered With Atorvastatin in Patients With Hypercholesterolemia (MK-6213-006)(COMPLETED)

Condition:   High Cholesterol
Interventions:   Drug: MK6213;   Drug: Comparator: atorvastatin calcium;   Drug: Comparator: placebo (unspecified)
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified August 2015

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Conditions:   Hypercholesteremia;   Hyperlipidemia
Interventions:   Drug: niacin (+) laropiprant;   Drug: Comparator : niacin
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified August 2015

Get CardioSmart

You're Invited